<SEC-DOCUMENT>0001599298-25-000030-index.html : 20250106
<SEC-HEADER>0001599298-25-000030.hdr.sgml : 20250106
<ACCEPTANCE-DATETIME>20250106194910
ACCESSION NUMBER:		0001599298-25-000030
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20250102
FILED AS OF DATE:		20250106
DATE AS OF CHANGE:		20250106

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			DUGGAN ROBERT W
		CENTRAL INDEX KEY:			0001055919
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36866
		FILM NUMBER:		25513136

	MAIL ADDRESS:	
		STREET 1:		611 SOUTH FORT HARRISON AVE
		STREET 2:		SUITE 306
		CITY:			CLEARWATER
		STATE:			FL
		ZIP:			33756

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Summit Therapeutics Inc.
		CENTRAL INDEX KEY:			0001599298
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				371979717
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		601 BRICKELL KEY DRIVE
		STREET 2:		SUITE 1000
		CITY:			MIAMI
		STATE:			FL
		ZIP:			33131
		BUSINESS PHONE:		305-203-2034

	MAIL ADDRESS:	
		STREET 1:		601 BRICKELL KEY DRIVE
		STREET 2:		SUITE 1000
		CITY:			MIAMI
		STATE:			FL
		ZIP:			33131

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Summit Therapeutics plc
		DATE OF NAME CHANGE:	20150219

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Summit Corp plc
		DATE OF NAME CHANGE:	20140205
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>wk-form4_1736210941.xml
<DESCRIPTION>FORM 4
<TEXT>
Document 1 - file: wk-form4_1736210941.html

Document 1 - RAW XML: wk-form4_1736210941.xml

</DOCUMENT>
</SEC-DOCUMENT>